Task: Answer the multiple-choice question.
Question: Which drug exhibits a -2.511% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCCc1nc2ccccc2n1CCOc1ccccc1
b) N#Cc1ccsc1NC(=O)CSc1nnnn1-c1ccc(O)cc1
c) COC(=O)C1=C(C)Nc2nnnn2C1c1ccccc1Cl
Answer: c. COC(=O)C1=C(C)Nc2nnnn2C1c1ccccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)C1=C(C)Nc2nnnn2C1c1ccccc1Cl
COC(=O)C1=C(C)Nc2nnnn2C1c1ccccc1Cl
methyl 7-(2-chlorophenyl)-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate